Evidence map›Paper›PMID 42365416›Full record

ArticleJournal of traditional Chinese medicine = Chung i tsa chih ying wen pan2026

Integrated analysis of plasma metabolomics and proteomics reveals the biological characteristics of damp-heat and stasis-toxin syndrome in colorectal cancer.

Qian Jingyang, Zhang Qinchang, Zhang Dong, Shi Heweng, Geng Xuechen, Sun Xiaohe, Sun Dongdong, Cheng Haibo

Abstract read
In one paragraph

Article in Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qian JingyangJiangsu Collaborative Innovation Center of Traditional Chinese Medicine in Prevention and Treatment of Tumor, the First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Zhang QinchangJiangsu Collaborative Innovation Center of Traditional Chinese Medicine in Prevention and Treatment of Tumor, the First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Zhang DongJiangsu Collaborative Innovation Center of Traditional Chinese Medicine in Prevention and Treatment of Tumor, the First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Shi HewengJiangsu Collaborative Innovation Center of Traditional Chinese Medicine in Prevention and Treatment of Tumor, the First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Geng XuechenJiangsu Collaborative Innovation Center of Traditional Chinese Medicine in Prevention and Treatment of Tumor, the First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Sun XiaoheJiangsu Collaborative Innovation Center of Traditional Chinese Medicine in Prevention and Treatment of Tumor, the First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Sun DongdongJiangsu Collaborative Innovation Center of Traditional Chinese Medicine in Prevention and Treatment of Tumor, the First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Cheng HaiboJiangsu Collaborative Innovation Center of Traditional Chinese Medicine in Prevention and Treatment of Tumor, the First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210023, China.

Funding

Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine: Inheritance and Innovation Team for Cancer Toxin Pathogenesis Theory in Prevention and Treatment of Gastrointestinal Malignancies ZYYCXTD-C-202208key project of the National Natural Science Foundation of China: Biological Basis of Core Pathogenesis Syndrome in Colorectal Cancer Liver Metastasis and the Mechanism of Action of Xianlian Jiedu Decoction in Prevention and Treatment 82430122National Key R&D Program of China: Research on Cancer Toxicity Pathogenesis Theory and Its Guidance for Prevention and Treatment Strategies of Malignant Tumors 2022YFC3500200National Key R&D Program of China: Research on Cancer Toxicity Pathogenesis Theory and Its Guidance for Prevention and Treatment Strategies of Malignant Tumors 2022YFC3500202
6 · The paper itself

Abstract

objectiveTo investigate the biological attributes of core syndromes in colorectal cancer, namely, the damp-heat and stasis-toxin syndrome (SRYD).

methodsBetween October 2021 and October 2022, a cohort comprising 40 patients with colorectal cancer (CRC) diagnosed with damp-heat and stasis-toxin syndrome (SRYD group), 40 patients with CRC without this syndrome (non-SRYD group), and 40 healthy controls (Normal group) was recruited at Jiangsu Province Hospital of Chinese Medicine. Untargeted metabolomics analysis was conducted on plasma samples from all 120 participants, while differential protein analysis using four-dimensional data-independent acquisition proteomics was performed on 20 randomly selected samples per group. A combined analysis of proteomics and metabolomics data followed, and the identified potential diagnostic biomarkers were subsequently used to train and validate multiple machine learning models.

resultsProteomic analysis revealed 130 differential proteins in the colorectal cancer with damp-heat and stasis-toxin syndrome (CRC-SRYD) group, enriched in pathways including complement and coagulation cascades, as well as nuclear factor kappa-B (NF-κB) signaling. Metabolomic analysis identified 584 differential metabolites within the same group, showing enrichment in pathways such as primary bile acid biosynthesis, central carbon metabolism in cancer, and glucagon signaling. Integrated pathway analysis indicated heightened activity of the NF-κB signaling pathway in the CRC-SRYD group. A biomarker panel, comprising 6 proteins and 9 metabolites selected through the ReliefF algorithm, was used to construct a diagnostic model with random forest, achieving an accuracy of 93.33%, sensitivity of 80.00%, and specificity of 100%.

conclusionThis study systematically elucidates plasma metabolomic and proteomic alterations in patients with CRC, establishing a robust diagnostic model for CRC syndrome (CRC-SRYD). Further investigation is warranted to clarify the underlying molecular mechanisms and biological foundations.

Indexed as

Colorectal NeoplasmsMetabolomicsAdultAgedBiomarkers, TumorFemaleHumansMaleMedicine, Chinese TraditionalMiddle AgedProteomicsBiomarkers, Tumorcolorectal neoplasmsdiagnostic modelsmulti-omics sequencingsyndrome differentiationTraditional Chinese Medicine syndrome

Identifiers

PMID42365416
PMCPMC13266320

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.